Related Articles
Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations
Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis
Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
Upregulation of phosphorylated cofilin 1 correlates with taxol resistance in human ovarian cancer in vitro and in vivo
Expression of UCP2 is associated with sensitivity to platinum‑based chemotherapy for ovarian serous carcinoma